Liver Med23 ablation improves glucose and lipid metabolism through modulating FOXO1 activity | |
Chu, YJ; Rosso, LG; Huang, P; Wang, ZC; Xu, YC; Yao, X; Bao, MH; Yan, J; Song, HY; Wang, G | |
刊名 | CELL RESEARCH |
2014 | |
卷号 | 24期号:10页码:1250-1265 |
关键词 | FOXO1 liver Med23-knockout mice gluconeogenesis insulin resistance obesity diabetes |
通讯作者 | Wang, G (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, 320 Yueyang Rd, Shanghai 200031, Peoples R China.,gwang@sibcb.ac.cn |
英文摘要 | Mediator complex is a molecular hub integrating signaling, transcription factors, and RNA polymerase II (RNAPII) machinery. Mediator MED23 is involved in adipogenesis and smooth muscle cell differentiation, suggesting its role in energy homeostasis. Here, through the generation and analysis of a liver-specific Med23-knockout mouse, we found that liver Med23 deletion improved glucose and lipid metabolism, as well as insulin responsiveness, and prevented diet-induced obesity. Remarkably, acute hepatic Med23 knockdown in db/db mice significantly improved the lipid profile and glucose tolerance. Mechanistically, MED23 participates in gluconeogenesis and cholesterol synthesis through modulating the transcriptional activity of FOXO1, a key metabolic transcription factor. Indeed, hepatic Med23 deletion impaired the Mediator and RNAPII recruitment and attenuated the expression of FOXO1 target genes. Moreover, this functional interaction between FOXO1 and MED23 is evolutionarily conserved, as the in vivo activities of dFOXO in larval fat body and in adult wing can be partially blocked by Med23 knockdown in Drosophila. Collectively, our data revealed Mediator MED23 as a novel regulator for energy homeostasis, suggesting potential therapeutic strategies against metabolic diseases. |
学科主题 | Cell Biology |
类目[WOS] | Cell Biology |
关键词[WOS] | TRANSCRIPTION FACTOR FOXO1 ; PROTEIN-KINASE B ; MEDIATOR COMPLEX ; GENE-EXPRESSION ; HEPATIC GLUCONEOGENESIS ; INSULIN SENSITIVITY ; LEPTIN RECEPTOR ; RNA-SEQ ; SUBUNIT ; PHOSPHORYLATION |
收录类别 | SCI |
语种 | 英语 |
WOS记录号 | WOS:000344993300012 |
内容类型 | 期刊论文 |
版本 | 出版稿 |
源URL | [http://202.127.25.143/handle/331003/234] |
专题 | 上海生化细胞研究所_上海生科院生化细胞研究所 |
推荐引用方式 GB/T 7714 | Chu, YJ,Rosso, LG,Huang, P,et al. Liver Med23 ablation improves glucose and lipid metabolism through modulating FOXO1 activity[J]. CELL RESEARCH,2014,24(10):1250-1265. |
APA | Chu, YJ.,Rosso, LG.,Huang, P.,Wang, ZC.,Xu, YC.,...&Wang, G.(2014).Liver Med23 ablation improves glucose and lipid metabolism through modulating FOXO1 activity.CELL RESEARCH,24(10),1250-1265. |
MLA | Chu, YJ,et al."Liver Med23 ablation improves glucose and lipid metabolism through modulating FOXO1 activity".CELL RESEARCH 24.10(2014):1250-1265. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论